Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Iran said to cut benefits on oil sales to India’s IOC, MRPL after reduced import April 8, 2017 LEC announces partnership with Option Cloudgate January 25, 2019 Siemens announces Xcelerator design software portfolio September 4, 2019